Trial Profile
Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary) ; Carboplatin; Gemcitabine
- Indications Carcinoma; Urogenital cancer
- Focus Therapeutic Use
- Acronyms JASINT1
- Sponsors Pierre Fabre
- 02 Feb 2019 This has been completed in Spain according to the European Clinical Trials Database record.
- 16 Dec 2015 Results published in the Annals of Oncology
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.